Nureca Ltd Share Price

₹285.15 -0.25 (-0.09%) BSE
as updated on 24-Dec-2025 16:59 | Sector - Healthcare

Day Range

  • Day's Low:282.00
  • Day's High:289.95

  • 52 Week Low198.00
  • 52 Week High447.00

Nureca Ltd's key Fundamentals

Market Cap ₹285 Cr.
P/E Ratio 115.3
TTM EPS 2.5
P/B Ratio 1.45
ROE -0.43
Debt to Equity 0.01
Face Value 10
BVPS 196.2
3 Year Sales Growth -23.45%

Nureca Ltd's Share Price Returns

1 Day -0.09%
1 Week 1.80%
1 Month 13.60%
3 Months 24.30%
6 Months 1.90%
1 Years 3.00%
3 Years -47.30%
5 Years 0.00%
10 Years 0%

Financial Ratio Analysis

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)

Check our DeciZen before investing

Check Stock Quality
Check Stock Valuation
Check Price Trend

Nureca Ltd Shareholding Pattern

Promoters

(64.97%)

Institutions

(0.07%)

Non-Institutions

(34.95%)

Pledged shares as % of Promoter's holding (%)

(0.00%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Balance Sheet

(All Figures are in Crores.)

Profit And Loss

(All Figures in Cr. Adjusted EPS in Rs.)

Cash Flow

(All Figures are in Crores.)

About Nureca Ltd

Nureca is a B2C company engaged in the business of home healthcare and wellness products, which offers quality, durability, functionality, usability and innovative designs. It enables its customers with tools to help them monitor chronic ailments and other diseases, to improve their lifestyle. It is a digital first company wherein it sells its products through online channel partners such as e-commerce players, distributors and retailer. Further, it also sells its products through its own website drtrust.in. 

The company has most of the product lines supporting home health market in India, making it a one-stop solution provider. Dr Trust is a known for its innovative products in the market, and, with the segment showing significant potential for growth, the company is positioned to show significant growth.

The company has a diversified product portfolio, which primarily caters to home healthcare sector. It provides an improved product mix to its customers and their preferences thereby targeting a wider customer base. Its growth is further driven by its ability to make available an assortment of quality products under trusted brands built by the company.

Products:

Currently, the company classify its products portfolio under the following five categories such as:

  • Chronic Device Products - which includes products such as blood pressure monitors, pulse oximeters, thermometers, nebulizers, self monitoring glucose devices, humidifier and steamers.
  • Orthopedic Products - which includes rehabilitation products such as wheelchairs, walkers, lumbar and tailbone supports and physiotherapy electric massagers.
    Mother and Child Products - which includes products such as breast pumps, bottle sterilizers, bottle warmers, car seats and baby carry cots.
  • Nutrition Supplements - which includes products such as fish oil, multivitamins, probiotics, botin, apple cider and vinegar.
  • Lifestyle Products - which includes products such as smart scales, aroma diffusers and fitness tracker.

Key awards, recognitions and accreditations

  • 2020: The company received ISO 9001:2015 Certificate of Registration from Intertek Certification Limited for Management System, which is applicable to sales, services and warehousing of medical devices, consumer electronics, pharmaceutical and personal care products.
  • 2020: Appreciation Letter from Pharmaceuticals Export Promoter Council of India stating the company as a very dynamic and evolving medical devices company and has created a credible and leading brand ‘Dr. Trust’ which is now a household name in India.

Major events and milestones:

  • 2016: Online launch of Dr. Trust Brand.
  • 2017: Launched Dr. Physio brand in electric massager categories and Trumom brand in mother and child care categories.
  • 2017: Started three flex centres in Punjab, Karnataka and Uttar Pradesh.
  • 2018: The company became the wholly owned subsidiary of Nectar Biopharma Private Limited.
  • 2018: Added three flex centres in Chandigarh, Telangana and Maharashtra.
  • 2018: Secured warehouse drug license.
  • 2020 Transfer and vesting of Specified Undertaking (as defined under the Scheme) from Nectar Biopharma Private Limited to the company pursuant to the Scheme of Arrangement.
Read More Read Less
Read More Read Less

Investment related blogs

Day Range

  • Day's Low: 282.00
  • Day's High: 289.95

  • 52 Week Low198.00
  • 52 Week High447.00

Nureca Ltd's key Fundamentals

Market Cap ₹285 Cr.
P/E Ratio 115.3
TTM EPS 2.5
P/B Ratio 1.45
ROE -0.43
Debt to Equity 0.01
Face Value 10
BVPS 196.2
3 Year Sales Growth -23.45%

Nureca Ltd's Share Price Returns

1 Day -0.09%
1 Week 1.80%
1 Month 13.60%
3 Months 24.30%
6 Months 1.90%
1 Years 3.00%
3 Years -47.30%
5 Years 0.00%
10 Years 0%

Investment related blogs

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×